Cone Health Cancer Center at Asheboro — Asheboro, North Carolina

Cone Health Cancer Center at Asheboro is a clinical research site located in Asheboro, North Carolina, United States 27203.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Cone Health Cancer Center at Asheboro has participated in 15 clinical trials with 14 currently active.

Therapeutic areas: Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), Wake Forest University Health Sciences, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Asheboro

Browse all research sites in North Carolina · View every site in Asheboro

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cone Health Cancer Center at Asheboro?

Cone Health Cancer Center at Asheboro has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cone Health Cancer Center at Asheboro conducted?

Cone Health Cancer Center at Asheboro has 15 clinical trials on record, with 14 currently active. Their work covers Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma.

Is Cone Health Cancer Center at Asheboro accredited by Crixeo Clinical Trials?

Cone Health Cancer Center at Asheboro has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cone Health Cancer Center at Asheboro?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.